Nom du produit:(S)-2-(3,5-Dimethylphenyl)pyrrolidine

IUPAC Name:(2S)-2-(3,5-dimethylphenyl)pyrrolidine

CAS:1213334-10-1
Formule moléculaire:C12H17N
Pureté:95%
Numéro de catalogue:CM198317
Poids moléculaire:175.28

Unité d'emballage Stock disponible Prix($) Quantité
CM198317-250mg in stock Ʀȡ
CM198317-1g in stock ǶȺư

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1213334-10-1
Formule moléculaire:C12H17N
Point de fusion:-
Code SMILES:CC1=CC(C)=CC([C@H]2NCCC2)=C1
Densité:
Numéro de catalogue:CM198317
Poids moléculaire:175.28
Point d'ébullition:
N° Mdl:MFCD07772459
Stockage:Keep in dark place, store at 2-8°C.

Category Infos

Pyrrolidines
Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

Column Infos

Aticaprant
Major depressive disorder is a leading cause of disability worldwide. Kappa opioid receptors (KORs) are a promising new therapeutic target for major depressive disorder and anhedonia. Aticaprant is a KOR antagonist developed by Johnson & Johnson’s Janssen. Aticaprant is currently being tested as an adjunctive therapy to a current antidepressant in MDD patients with a focus on treating anhedonia. Studies are expected to be completed in mid-to-late 2024 and 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.